Product Information
CEFDINIR 125 MG/5 ML SUSP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1133 per ML under NDC 67877054798. Its NADAC has been published 264 times since Aug 4, 2021.
FDA first approved this application on Feb 19, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
Ascend Laboratories, LLCNDC
67877054798
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA210534FDA Approved
2/19/2021
TE Code
AB
On Market Since
2/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 125 MG/5 ML SUSP has been published 264 times since Aug 4, 2021, and over the history we have for it it has declined 26.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1133 per ML |
|---|---|
| All-time high | $0.1941 (Jun 14, 2023) |
| All-time low | $0.1125 (Apr 17, 2024) |
| 52-week high | $0.1263 |
| 52-week low | $0.1133 |
| Median price | $0.1387 |
| Average price | $0.1402 |
| Largest weekly change | +33.3% (Jun 19, 2024) |
| Weeks tracked | 264 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFDINIR 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 125 MG/5 ML SUSP, manufactured by Ascend Laboratories, LLC, is $0.1133 per ML (NDC 67877054798), effective Aug 19, 2026.
How has the price of CEFDINIR 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFDINIR 125 MG/5 ML SUSP has declined 26.4%. It has been tracked across 264 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for CEFDINIR 125 MG/5 ML SUSP?
Since Aug 4, 2021, the NADAC for CEFDINIR 125 MG/5 ML SUSP has ranged from a low of $0.1125 (Apr 17, 2024) to a high of $0.1941 (Jun 14, 2023), with a median of $0.1387 per ML.
Are there cheaper alternatives to CEFDINIR 125 MG/5 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFDINIR 125 MG/5 ML SUSP, is $0.1063 per ML — about 6% below CEFDINIR 125 MG/5 ML SUSP.
Who manufactures CEFDINIR 125 MG/5 ML SUSP?
CEFDINIR 125 MG/5 ML SUSP (NDC 67877054798) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.